tetano
Editor, Senior Moderator
Pathog Dis. 2020 Apr 6. pii: ftaa017. doi: 10.1093/femspd/ftaa017. [Epub ahead of print]
Exacerbation of disease by intranasal liquid administration following influenza virus infection in mice.
Lyu Y[SUP]1[/SUP], Li P[SUP]2[/SUP], Yang Z[SUP]3[/SUP], Zhong N[SUP]1[/SUP].
Author information
Abstract
Although numerous studies have clarified the synergistic pathogenesis in mouse models of influenza A virus (IAV) associated dual infections, fewer studies have investigated the influence of intranasal liquid administration on the disease. This study explored the effects of intranasal PBS administration in mouse models of mimic IAV dual infection and the infectious dose of IAV that caused equivalent pathogenesis in different dual infection models. Weights, survival rates, virus loads, lung indexes and lung pathology were compared. We demonstrated that intranasal PBS administration following H1N1 or H3N2 infection increased weight loss, mortality, virus replication and lung damage. No difference was observed if the order was reversed or PBS was given simultaneously with IAV. To induce equivalent virulence, a 20-fold difference in the infectious dose was needed when the H3N2-PBS superinfection and H3N2-PBS coinfection or PBS-H3N2 superinfection groups were compared. Our study demonstrated that the unfavourable effect of intranasal liquid administration should not be neglected and that both the strain and infectious dose of IAV should be considered to avoid an illusion of synergistic pathogenicity when establishing IAV associated dual infection model. A 20 fold lower dose than that of coinfection may be a better choice for secondary infection following IAV.
? FEMS 2020.
KEYWORDS:
coinfection; dual infection; influenza A virus; intranasal liquid administration; superinfection; synergistic pathogenesis
PMID:32250390DOI:10.1093/femspd/ftaa017
Exacerbation of disease by intranasal liquid administration following influenza virus infection in mice.
Lyu Y[SUP]1[/SUP], Li P[SUP]2[/SUP], Yang Z[SUP]3[/SUP], Zhong N[SUP]1[/SUP].
Author information
Abstract
Although numerous studies have clarified the synergistic pathogenesis in mouse models of influenza A virus (IAV) associated dual infections, fewer studies have investigated the influence of intranasal liquid administration on the disease. This study explored the effects of intranasal PBS administration in mouse models of mimic IAV dual infection and the infectious dose of IAV that caused equivalent pathogenesis in different dual infection models. Weights, survival rates, virus loads, lung indexes and lung pathology were compared. We demonstrated that intranasal PBS administration following H1N1 or H3N2 infection increased weight loss, mortality, virus replication and lung damage. No difference was observed if the order was reversed or PBS was given simultaneously with IAV. To induce equivalent virulence, a 20-fold difference in the infectious dose was needed when the H3N2-PBS superinfection and H3N2-PBS coinfection or PBS-H3N2 superinfection groups were compared. Our study demonstrated that the unfavourable effect of intranasal liquid administration should not be neglected and that both the strain and infectious dose of IAV should be considered to avoid an illusion of synergistic pathogenicity when establishing IAV associated dual infection model. A 20 fold lower dose than that of coinfection may be a better choice for secondary infection following IAV.
? FEMS 2020.
KEYWORDS:
coinfection; dual infection; influenza A virus; intranasal liquid administration; superinfection; synergistic pathogenesis
PMID:32250390DOI:10.1093/femspd/ftaa017